title: Significance of WBC differential when leukopenia is induced by 6-MP for IBD.
authors.forename: B I
authors.initials: BI
authors.lastname: Korelitz
authors.forename: J
authors.initials: J
authors.lastname: Zlatanic
authors.forename: M J
authors.initials: MJ
authors.lastname: Smith
authors.forename: R J
authors.initials: RJ
authors.lastname: Lipe
authors.forename: P J
authors.initials: PJ
authors.lastname: Baiocco
authors.forename: G W
authors.initials: GW
authors.lastname: Gleim
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007962:Leukocytes / Q000187:drug effects*; D007970:Leukopenia / Q000139:chemically induced*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects*; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine